Publisher
Springer Science and Business Media LLC
Subject
Medicine (miscellaneous),Immunology and Allergy
Reference48 articles.
1. Alvarez-Cuesta E, Madrigal-Burgaleta R, Broyles AD, Cuesta-Herranz J, Guzman-Melendez MA, Maciag MC, et al. Standards for practical intravenous rapid drug desensitization & delabeling: a WAO committee statement. World Allergy Organization Journal. 2022;in press. Thorough article authored by leading teams in the field and focusing on the practicalities of intravenous drug delabeling and drug desensitization, including very relevant information on diagnostic pathways, the design of dedicated spaces, governance, and management.
2. Berges-Gimeno MP, Carpio-Escalona LV, Longo-Munoz F, Bernal-Rubio L, Lopez-Gonzalez P, Gehlhaar P, et al. Does rapid drug desensitization to chemotherapy affect survival outcomes? J Investig Allergol Clin Immunol. 2020;30(4):254–63 Survival study comparing data from desensitized patients and controls shows how patients desensitized to oxaliplatin have the same survival outcomes as nonallergic patients.
3. Sloane D, Govindarajulu U, Harrow-Mortelliti J, Barry W, Hsu FI, Hong D, et al. Safety, costs, and efficacy of rapid drug desensitizations to chemotherapy and monoclonal antibodies. J Allergy Clin Immunol Pract. 2016;4(3):497–504.
4. Hong DI, Madrigal-Burgaleta R, Banerji A, Castells M, Alvarez-Cuesta E. Controversies in allergy: chemotherapy reactions, desensitize, or delabel? J Allergy Clin Immunol Pract. 2020;8(9):2907-15 e1. A critical view of diagnostic pathways and the role of risk assessment and multidisciplinary teams in allergy to chemotherapy and biologics.
5. Madrigal-Burgaleta R, Vazquez-Revuelta P, Marti-Garrido J, Lleonart-Bellfill R, Ali FR, Alvarez-Cuesta E. Medical algorithm: diagnosis and treatment of hypersensitivity reactions to cancer chemotherapy. Allergy. 2021;76(8):2636–40. A brief and accessible review of diagnosis and treatment in chemotherapy allergy.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献